UK Investment Life Sci Firm Arix Bioscience Hits £100 Million IPO Goal

Published: Feb 17, 2017

Arix Bioscience (LON:ARIX) rose to a modest premium in the first hour of trading in London.

The shares, listed at 207p, advanced 3p on thin volumes.

Arix raised £100mln as part of the float – money that will be ploughed into early-stage drug developers and university partnerships.

Back to news